Stay updated on Olaparib Maintenance in BRCA Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Olaparib Maintenance in BRCA Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Olaparib Maintenance in BRCA Ovarian Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0 while the study page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T15:48:56.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    A site-wide banner announces NIH’s transition from “Artificial Intelligence” to “Super Intelligence” terminology and links to related updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T15:46:12.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer revision number was updated from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T22:17:31.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T22:05:29.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    - The page now renders a 403 Forbidden error instead of the study record content, blocking access to the trial details and documents.
    Difference
    17%
    Check dated 2026-09-20T20:49:22.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Israel study site list updated: Tel Litwinsky added as a study location and Qiryat Krinitzi removed. This changes the enrollment options for participants in Israel.
    Difference
    0.1%
    Check dated 2026-09-13T21:55:10.000Z thumbnail image

Stay in the know with updates to Olaparib Maintenance in BRCA Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Olaparib Maintenance in BRCA Ovarian Cancer Clinical Trial page.